JMIRx Med,
Journal Year:
2023,
Volume and Issue:
4, P. e34598 - e34598
Published: Feb. 13, 2023
Emerging
SARS-CoV-2
variants
have
been
attributed
to
the
occurrence
of
secondary,
tertiary,
quaternary,
and
quinary
COVID-19
epidemic
waves
threatening
vaccine
efforts
owing
their
immune
invasiveness.
Since
importation
in
South
Africa,
with
first
reported
case
on
March
5,
2020,
Africa
has
observed
5
consecutive
waves.
The
evolution
played
a
major
role
resurgence
across
globe.
Mathematics,
Journal Year:
2023,
Volume and Issue:
11(2), P. 369 - 369
Published: Jan. 10, 2023
The
aim
of
this
paper
is
to
investigate
the
qualitative
behavior
COVID-19
pandemic
under
an
initial
vaccination
program.
We
constructed
a
mathematical
model
based
on
nonlinear
system
delayed
differential
equations.
time
delay
represents
that
vaccine
takes
provide
immune
protection
against
SARS-CoV-2.
impact
transmission
rates,
vaccination,
and
dynamics
system.
was
developed
for
beginning
implementation
programs
control
pandemic.
perform
stability
analysis
at
equilibrium
points
show,
using
methods
systems,
undergoes
Hopf
bifurcation.
theoretical
results
reveal
some
conditions
related
values
parameters
basic
reproduction
number,
approaches
disease-free
point,
but
if
number
larger
than
one,
endemic
SARS-CoV-2
cannot
be
eradicated.
Numerical
examples
corroborate
methodology.
Finally,
conclusions
discussions
about
are
presented.
Journal of Medical Virology,
Journal Year:
2021,
Volume and Issue:
94(4), P. 1300 - 1314
Published: Nov. 23, 2021
Young
age,
female
sex,
absence
of
comorbidities,
and
prior
infection
or
vaccination
are
known
epidemiological
barriers
for
contracting
the
new
and/or
increased
disease
severity.
Demographic
trends
from
recent
coronavirus
2019
waves,
which
believed
to
be
driven
by
newer
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
variants,
indicate
that
aforementioned
being
breached
a
larger
number
younger
healthy
individuals
developing
disease.
The
SARS-CoV-2
variants
have
key
mutations
can
induce
significant
changes
in
virus-host
interactions.
Recent
studies
report
that,
some
these
mutations,
singly
group,
enhance
mechanisms,
such
as
binding
receptor-binding
domain
(RBD)
viral
spike
protein
with
angiotensin-converting
enzyme
(ACE2)
receptor
host-cells,
increase
glycosylation
at
antigenic
sites,
proteolytic
cleavage
protein,
thus
leading
improved
host-cell
entry
replication
virus.
putative
interactions
imparted
RBD
sequence
potentially
reason
behind
breach
observed
barriers.
Susceptibility
outcomes
influenced
expressions
ACE2
other
proteases.
act
more
efficiently,
even
lesser
availability
entry-receptor
associated
proteases,
efficient
greater
resulting
high
loads
prolonged
shedding,
widespread
tissue-injury,
inflammation
transmissibility
lethality.
Furthermore,
accumulating
evidence
shows
multiple
reduced
neutralization
both,
natural
vaccine-acquired
antibodies,
indicating
repeated
vaccine
breakthrough
infections
may
arise
serious
health
concerns
ongoing
pandemic.
Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: Feb. 17, 2022
We
develop
a
mathematical
model
to
estimate
the
effect
of
New
Zealand's
vaccine
rollout
on
potential
spread
and
health
impacts
COVID-19.
The
main
purpose
this
study
is
provide
basis
for
policy
advice
border
restrictions
control
measures
in
response
outbreaks
that
may
occur
during
vaccination
roll-out.
can
be
used
theoretical
population
immunity
threshold,
which
represents
point
at
other
controls
could
removed
only
small,
occasional
would
take
place.
find
that,
with
basic
reproduction
number
6,
approximately
representing
Delta
variant
SARS-CoV-2,
under
baseline
effectiveness
assumptions,
reaching
threshold
require
close
100%
total
vaccinated.
Since
coverage
not
likely
achievable
practice,
relaxing
completely
risk
serious
impacts.
However,
higher
is,
more
collective
protection
has
against
adverse
outcomes
from
COVID-19,
easier
it
will
become
outbreaks.
There
remains
considerable
uncertainty
outputs,
part
because
evolution
new
variants.
If
variants
arise
are
transmissible
or
resistant,
an
increase
needed
same
level
protection.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Aug. 22, 2022
Control
and
mitigation
of
the
COVID-19
pandemic
in
England
has
relied
on
a
combination
vaccination
non-pharmaceutical
interventions
(NPIs).
Some
these
NPIs
are
extremely
costly
(economically
socially),
so
it
was
important
to
relax
promptly
without
overwhelming
already
burdened
health
services.
The
eventual
policy
Roadmap
four
relaxation
steps
throughout
2021,
taking
from
lock-down
cessation
all
restrictions
social
interaction.
In
series
six
documents
generated
models
assessed
potential
risk
each
step.
Here
we
show
that
model
projections
reliable
estimation
medium-term
hospital
admission
trends,
with
data
points
up
September
2021
generally
lying
within
our
95%
prediction
intervals.
greatest
uncertainties
modelled
scenarios
came
vaccine
efficacy
estimates
against
novel
variants,
assumptions
about
human
behaviour
face
changing
risk.
Journal of Biomedical Science,
Journal Year:
2022,
Volume and Issue:
29(1)
Published: July 3, 2022
Many
countries
in
Asia
and
Latin
America
are
currently
facing
a
double
burden
of
outbreaks
due
to
dengue
COVID-19.
Here
we
discuss
the
similarities
differences
between
two
infections
so
that
lessons
learnt
far
from
studying
both
will
be
helpful
further
understanding
their
immunopathogenesis
develop
therapeutic
interventions.
Current Drug Targets,
Journal Year:
2022,
Volume and Issue:
23(17), P. 1593 - 1602
Published: Aug. 27, 2022
Abstract:
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
is
the
highly
patho-genic
and
transmissible
human
coronavirus
that
causative
agent
for
worldwide
COVID-19
pandemic.
manifests
predominantly
as
a
respiratory
illness
with
symptoms
consistent
viral
pneumonia,
but
other
organ
systems
(e.g.,
kidney,
heart,
brain)
can
also
be-come
perturbed
in
patients.
Accumulating
data
suggest
significant
activation
of
hemostatic
system
common
pathological
manifestation
SARS-CoV-2
infection.
The
clotting
protein
fibrinogen
one
most
abundant
plasma
proteins.
Following
coagulation,
central
coagulation
protease
thrombin
converts
to
fibrin
monomers,
which
self-assemble
form
matrix,
primary
structural
component
blood
clot.
associated
profound
perturbation
circulating
fibrinogen,
intra-
extravascular
deposition
persistence,
degradation.
Current
findings
high
levels
fibrino-gen
degradation
product
D-dimer
are
biomarkers
poor
prognosis
COVID-19.
Moreover,
emerging
studies
vitro
animal
models
indicate
fibrin(ogen)
an
active
play-er
pathogenesis.
Here,
we
review
current
literature
regarding
COVID-19,
including
possible
pathogenic
mechanisms
treatment
strategies
centered
on
function.
Journal of The Royal Society Interface,
Journal Year:
2023,
Volume and Issue:
20(199)
Published: Feb. 1, 2023
New
Zealand
experienced
a
wave
of
the
Omicron
variant
SARS-CoV-2
in
early
2022,
which
occurred
against
backdrop
high
two-dose
vaccination
rates,
ongoing
roll-out
boosters
and
paediatric
doses,
negligible
levels
prior
infection.
subvariants
have
subsequently
emerged
with
significant
growth
advantage
over
previously
dominant
BA.2.
We
investigated
mathematical
model
that
included
waning
vaccine-derived
infection-derived
immunity,
as
well
impact
BA.5
subvariant
began
spreading
May
2022.
The
was
used
to
provide
scenarios
Government
differing
advantage,
helping
inform
policy
response
healthcare
system
preparedness
during
winter
period.
In
all
investigated,
projected
peak
new
infections
smaller
than
first
March
However,
results
indicated
hospital
occupancy
likely
be
higher
primarily
due
shift
age
distribution
older
groups.
compare
subsequent
epidemiological
data
show
provided
good
projection
cases,
hospitalizations
deaths
wave.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: July 13, 2023
Background
Breakthrough
infections
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
are
increasingly
observed
in
vaccinated
individuals.
Immune
responses
towards
SARS-CoV-2
variants,
particularly
Omicron-BA.5,
poorly
understood.
We
investigated
the
humoral
and
cellular
immune
of
hospitalized
COVID-19
patients
during
Delta
Omicron
infection
waves.
Methods
The
corresponding
variant
respective
were
identified
by
whole
genome
sequencing.
Humoral
analyzed
ELISA
a
cell
culture-based
neutralization
assay
against
D614G
isolate
(wildtype),
Alpha,
(AY.43)
(BA.1
BA.5).
Cellular
immunity
was
evaluated
an
IFN-γ
ELISpot
assay.
Results
On
level,
showed
minor
response
after
stimulating
PBMCs
mutated
regions
variants.
Neutralizing
antibody
titers
Omicron-BA.1
especially
BA.5
strongly
reduced.
Double-vaccinated
breakthrough
significantly
increased
neutralizing
compared
to
double-vaccinated
uninfected
controls
(median
complete
titer
(NT
100
)
640
versus
80,
p<0.05).
BA.1
NT
160
20
controls,
p=0.07)
that
received
booster
vaccination
50
p=0.68).
For
boosted
infection,
we
found
no
enhancing
effect
on
Conclusion
reduced
infections.
but
not
Omicron-BA.5
vaccination.
Despite
those
may
still
be
vulnerable
for
reinfections
or
other
newly
emerging
concern.